Your browser doesn't support javascript.
Comparison of antibody responses to SARS-CoV-2 variants in Australian children.
Toh, Zheng Quan; Mazarakis, Nadia; Nguyen, Jill; Higgins, Rachel A; Anderson, Jeremy; Do, Lien Anh Ha; Burgner, David P; Curtis, Nigel; Steer, Andrew C; Mulholland, Kim; Crawford, Nigel W; Tosif, Shidan; Licciardi, Paul V.
  • Toh ZQ; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Mazarakis N; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
  • Nguyen J; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Higgins RA; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Anderson J; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Do LAH; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Burgner DP; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
  • Curtis N; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Steer AC; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
  • Mulholland K; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Crawford NW; Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia.
  • Tosif S; Department of General Medicine, The Royal Children's Hospital, Parkville, VIC, Australia.
  • Licciardi PV; Infection and Immunity, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Nat Commun ; 13(1): 7185, 2022 Nov 23.
Article in English | MEDLINE | ID: covidwho-2133435
ABSTRACT
There is limited understanding of antibody responses in children across different SARS-CoV-2 variants. As part of an ongoing household cohort study, we assessed the antibody response among unvaccinated children infected with Wuhan, Delta, or Omicron variants, as well as vaccinated children with breakthrough Omicron infection, using a SARS-CoV-2 S1-specific IgG assay and surrogate virus neutralization test (% inhibition). Most children infected with Delta (100%, 35/35) or Omicron (81.3%, 13/16) variants seroconverted by one month following infection. In contrast, 37.5% (21/56) children infected with Wuhan seroconverted, as previously reported. However, Omicron-infected children (geometric mean concentration 46.4 binding antibody units/ml; % inhibition = 16.3%) mounted a significantly lower antibody response than Delta (435.5 binding antibody untis/mL, % inhibition = 76.9%) or Wuhan (359.0 binding antibody units/mL, % inhibition = 74.0%). Vaccinated children with breakthrough Omicron infection mounted the highest antibody response (2856 binding antibody units/mL, % inhibition = 96.5%). Our findings suggest that despite a high seropositivity rate, Omicron infection in children results in lower antibody levels and function compared with Wuhan or Delta infection or with vaccinated children with breakthrough Omicron infection. Our data have important implications for public health measures and vaccination strategies to protect children.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines / Variants Limits: Child / Humans Country/Region as subject: Oceania Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-34983-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines / Variants Limits: Child / Humans Country/Region as subject: Oceania Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-34983-2